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Simple Summary: Bystander effects depend on direct cell-cell communication and/or paracrine sig-
naling mediated by the release of soluble factors into the extracellular environment and may greatly
influence therapy outcome. Although the limited data available suggest a role for intercellular gap
junction channels, far less is known about the role of connexin hemichannels. Here, we investigated
bystander effects induced by photodynamic therapy in syngeneic murine melanoma models in vivo.
We determined that (i) photoactivation of a photosensitizer triggered calcium-dependent cell death path-
ways in both irradiated and bystander tumor cells; (ii) hemichannel activity and adenosine triphosphate
release were key factors for the induction of bystander cell death; and (iii) bystander cell killing and
antitumor response elicited by photodynamic therapy were greatly enhanced by combination treatment
with S-nitrosoglutathione, which promoted hemichannel opening in these experimental conditions.
Therefore, these findings in a preclinical model have important translational potential.
Abstract: In this study, we used B16-F10 cells grown in the dorsal skinfold chamber (DSC) preparation
that allowed us to gain optical access to the processes triggered by photodynamic therapy (PDT). Partial
irradiation of a photosensitized melanoma triggered cell death in non-irradiated tumor cells. Multipho-
ton intravital microscopy with genetically encoded fluorescence indicators revealed that bystander cell
death was mediated by paracrine signaling due to adenosine triphosphate (ATP) release from connexin
(Cx) hemichannels (HCs). Intercellular calcium (Ca2+) waves propagated from irradiated to bystander
cells promoting intracellular Ca2+ transfer from the endoplasmic reticulum (ER) to mitochondria and
rapid activation of apoptotic pathways. Combination treatment with S-nitrosoglutathione (GSNO),
an endogenous nitric oxide (NO) donor that biases HCs towards the open state, greatly potentiated
anti-tumor bystander killing via enhanced Ca2+ signaling, leading to a significant reduction of post-
irradiation tumor mass. Our results demonstrate that HCs can be exploited to dramatically increase
cytotoxic bystander effects and reveal a previously unappreciated role for HCs in tumor eradication
promoted by PDT.
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1. Introduction
It has long been known that damage to cells directly hit by ionizing radiation can
propagate to neighboring non-irradiated cells giving rise to the so-called radiation-induced
bystander effect [1]. Bystander responses have been reported also downstream of other in-
sults [2], including PDT [3–7], which requires the assimilation by tumor cells of a photosen-
sitizer (PS) that remains inert and non-toxic until excited by light, whereas light-activated
PS triggers cascades of highly cytotoxic reactive oxygen/nitrogen species (ROS/RNS)
promoting tumor cell death [8].
Bystander effects depend on direct cell-cell communication and/or paracrine signaling
mediated by the release of soluble factors into the extracellular environment and Cxs, a
family of membrane proteins with four transmembrane helices, are involved in both type
of processes [9]. Cxs form hexameric plasma membrane channels with large aqueous pores
termed connexons or HCs [10]. Two HCs, each one from different cells in contact, may form
an intercellular gap junction channel (IGJC) after docking head-to-head in the extracellular
space and IGJCs have been implicated in bystander cell killing triggered by gene therapy
for cancer [11], as well as ionizing radiation [12]. Although the limited data available also
suggest a role for IGJCs in PDT-induced bystander effects, very little is known about the
contribution of HCs [13].
In physiological conditions, HCs are usually closed, but a variety of factors may
induce their opening, including protein phosphorylation or redox state, changes in pH
or transmembrane voltage, metabolic inhibition, as well as NO and divalent cations [14].
In particular, the opening of several species of HCs is favored under conditions of low
extracellular Ca2+ concentration ([Ca2+]ex) [14,15]. The open probability of HCs also varies
in response to changes in the cytosolic Ca2+ concentration ([Ca2+]cyt), with a bell-shaped
dependence peaking at 500 nM [16–18]. Open HCs can mediate the diffusive release of
several paracrine messengers, most importantly ATP [19].
Our published results with aluminum phthalocyanine chloride (AlPcCl) in tumori-
genic murine cell lines indicate that photoactivation of this PS triggers apoptosis in by-
stander tumor cells via propagation of intercellular Ca2+ waves that proceed from irradiated
to bystander cells. AlPcCl activation also promotes NO production, a gaseous molecule
that diffuses freely across plasma membranes and can enter bystander cells, in which
NO concentration is further increased by a mechanism compatible with Ca2+-dependent
enzymatic production [20–22].
Here, we analyzed bystander signaling and apoptosis induced by photoactivation of
AlPcCl in vivo, in syngeneic mouse melanomas. We show that pharmacological treatments
that favor HC opening enhanced ATP-dependent intercellular Ca2+ waves elicited by PS
activation and increased bystander tumor cell killing, leading to a dramatic reduction of
post-irradiation tumor volumes compared to PDT with PS alone.
2. Materials and Methods
2.1. Cells
2.1.1. Lentiviral Vector Production
Lentiviral plasmid encoding GCaMP6s and mCherry were purchased from Addgene
(Watertown, MA, USA; #80146, a gift from Dr. Darrell Kotton and pUltra-hot, and #24130,
a gift from Dr. Malcolm Moore, respectively). Lentiviral plasmid encoding caspase-3
(Cas-3) indicator was engineered in the lab using the pUltra-hot lentiviral vector for
bi-cistronic expression of mCherry and Cas-3 indicator (GANLS-DEVD-BNES, #50835,
Addgene, a gift from Dr. Robert Campbell). Lentiviral plasmids encoding organelle-
targeted Ca2+ indicators (R-CEPIA1er, G-CEPIA1er and CEPIA2mt) were a gift from Dr.
Masamitsu Iino lab. Lentiviruses (LVs) were produced by transfection of HEK-293T cells
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(Cat. No. CRL-3216, American Type Culture Collection, ATCC, Manassas, VA, USA) using
Lipofectamine 2000 (Cat. No. 11668-027, Thermo Fisher Scientific, Waltham, MA, USA).
Supernatant containing viral particles was collected, cleared by centrifugation, and frozen
at −80 ◦C for later usage.
2.1.2. Engineering of B16-F10 Cells Expressing Fluorescent Indicators
B16-F10 mouse melanoma cells were obtained from ATCC (Cat. No. CRL-6475) and
maintained in RPMI 1640-GlutaMAX (Cat. No. 61870-010, Thermo Fisher Scientific), supple-
mented with heat-inactivated fetal bovine serum (FBS, 10% v/v, Cat. No. 10270-106, Thermo
Fisher Scientific) and penicillin/streptomycin solution (100 units/mL penicillin, 100 µg/mL
streptomycin, Cat. No. 15070-063, Thermo Fisher Scientific). Cells were routinely tested for
mycoplasma contamination by staining with 4′,6-Diamidine-2′-phenylindole dihydrochlo-
ride (DAPI, Cat. No. D1306, Thermo Fisher Scientific) followed by visual inspection at
the fluorescence microscope. The day before LV infection, cells were plated at 30% con-
fluence into a 35-mm Petri dish. Cells were pre-incubated in complete RPMI medium
supplemented with hexadimethrine bromide (16 µg/mL, Cat. No. H9268, Merck KGaA,
Darmstadt, Germany) at 37 ◦C for 30 min, then RPMI was replaced by 0.5 mL of LV-
containing supernatant supplemented with hexadimethrine bromide (16 µg/mL). Cells
were incubated for 3 h with the LV-containing medium alone to maximize infection effi-
ciency, and then 1.5 mL of fresh culture medium was added to allow the incubation to
continue overnight.
2.2. Animals
C57BL/6J mice were bred under controlled pathogen-free conditions at the National
Research Council-Institute of Biochemistry and Cell Biology (CNR-IBBC), Infrafrontier/
ESFRI-European Mouse Mutant Archive (EMMA), Monterotondo, Rome, Italy. At the end
of experiments, mice were euthanized by cervical dislocation.
2.3. Surgical Procedures and Tumor Implantation
DSCs (Cat. No. SM100, APJ Trading Inc., Ventura, CA, USA) were mounted on
10–14-week-old male mice. During surgery, we removed a portion of the upper skin layer
inside the DSC window using precision surgical scissors to expose the subcutaneous tissue.
For multiphoton imaging experiments, the biopsy corresponded to the dorsal window area
(12 mm ∅), whereas for longitudinal studies after PDT treatments, a punch biopsy was
performed with a round scalpel (4 mm ∅, Cat. No. BP-40F, KAI Industries Co., Seki, Japan).
The window chamber was then sealed with a sterilized, removable 12-mm ∅ round glass
coverslip. On the same day, B16-F10 cells were infected with LV expressing the protein
of interest. The day after, LV-transduced B16-F10 cells were collected in ice-cold HBSS
(Cat. No. 14025-050, Thermo Fisher Scientific) for seeding onto the exposed subdermal
tissue within the DSC biopsy. Chamber-bearing mice were transiently anesthetized with
2% gaseous isoflurane and a certain amount of cell suspension was dropped onto the
subcutaneous tissue (5 × 105 cells in a total volume of 30 µL for multiphoton imaging
experiments and 3 × 105 cells in a total volume of 8 µL for longitudinal studies). For
longitudinal experiments after full PDT (see Section 2.8), mice were kept anesthetized for at
least 40 min after cell seeding to promote sedimentation on subdermal tissue and increase
uniformity of tumor growth across experiments. All mice were checked daily to monitor
health conditions, melanoma progression and expression of fluorescent indicators.
2.4. Focal PDT (fPDT) and Multiphoton Intravital Microscopy of Melanomas Expressing
Genetically Encoded Fluorescent Indicators
Four to five days after inoculation of indicator-expressing tumor cells, tumor-bearing
mice were anesthetized with 2% isoflurane and maintained at 37 ◦C on a controlled heating
pad. The 12-mm-round glass coverslip that sealed the DSC window was removed and the
tumor grown in the exposed subcutaneous tissue was incubated for 1 h with PS (AlPcCl,
100 µM, Cat. No. 362530, Merck KGaA) dissolved in normal extracellular medium (NEM:
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138 mM NaCl, 5 mM KCl, 2 mM CaCl2, 0.4 mM NaH2PO4, 6 mM D-Glucose, 10 mM HEPES,
all purchased from Merck KGaA, pH 7.3), supplemented with the nonionic surfactant agent
pluronic F-127 (1% w/v, Cat. No. 20053, AAT Bioquest, Sunnyvale, CA, USA) to facilitate PS
solubilization. Next, mice were transferred to the multiphoton microscope stage, where the
DSC was fixed to a custom-made holder to reduce motion artifacts due to animal breathing.
The exposed tumor in the DSC was washed and incubated in fresh NEM as immersion
medium for the objective for fPDT simultaneous to intravital multiphoton microscopy.
For fPDT, a single cell at the surface of the tumor was irradiated with light from a
fiber-coupled 671-nm diode-pumped solid-state laser (Shanghai Dream Lasers Technology,
Shanghai, China), as described in [22]. Briefly, the recollimated laser beam was injected into
the microscope optical path just above the 60× water immersion objective (Nikon Fluor
60×Water, NA = 1.0, WD = 2 mm, Nikon, Tokyo, Japan) and focused into a 10-µm ∅ spot.
During imaging experiments, the 671-nm (activation) laser was electronically triggered to
deliver 5.5 ms flashes in the time interval between consecutive frames at an irradiance of
~5 × 106 mW/cm2.
Multiphoton excitation of fluorescent indicators was provided by a femtosecond
pulsed titanium-sapphire pump laser (Chameleon Ultra II Laser, Coherent Inc., Santa
Clara, CA, USA) coupled to an optical parametric oscillator (MPX Chameleon Compact
OPO, Coherent Inc.). Fluorescence signals were detected by cooled GaAsP photomultiplier
modules (Cat. No. H7422-40, Hamamatsu Photonics, Hamamatsu, Japan) at 5.1 frames/s.
Green fluorescent indicators (GCaMP6s, G-CEPIA1er, CEPIA2mt, and GANLS-DEVD-
BNES) were excited at 920 nm and fluorescence emission was collected by a 525/40 nm
band pass filter (Cat. No. FF02-525/40-25, Semrock, Rochester, NY, USA). R-CEPIA1er
was excited at 1100 nm and mCherry was excited at 980 nm; red emission signals from
these fluorescent indicators/proteins were selected by 612/69 nm band pass filter (Cat.
No. FF01-612/69-25, Semrock).
For some fPDT experiments, GCaMP6s-expressing tumors in the DSC were incubated
in Ca2+-free extracellular medium (CFEM, i.e., NEM devoid of Ca2+), supplemented with
5 mM of ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA, Cat.
No. E3889, Merck KGaA) with or without HC inhibitors, carbenoxolone (CBX, 100 µM, Cat.
No. C4790, Merck KGaA), flufenamic acid (FFA, 100 µM, Cat. No. F9005, Merck KGaA),
TAT-Gap19 (150 µM, peptide YGRKKRRQRRRKQIEIKKFK, Genosphere Biotechnologies,
Clamart, France), and abEC1.1m (1 µM; for production methods see [23]; Shanghai Institute
for Advanced Immunochemical Studies, ShanghaiTech University, 201210 Shanghai, China)
for 20 min before the experiment. Tumors were randomly assigned to a single drug
treatment and each one was used for several measurements performed in non-overlapping
areas of the sample. Thereafter, washout was performed with fresh NEM for 30 min and
experiments were repeated in CFEM supplemented with 5 mM of EGTA alone to confirm
the reversible effect of HC blockers. We stopped data collection when at least n = 6 fPDT
trials were performed in at least 2 tumors and pooled the results. Typical numbers of
bystander cells (classified within a “bystander cell order” according to their distance from
the irradiated cell, see Figure 1A) that were monitored in a single fPDT trial were: 1st order,
3; 2nd order, 6; 3rd order, 7; 4th order, 6, 5th order, 5; and 6th order, 2. The investigator was
not blinded during administration of treatments or result assessment. No samples were
excluded from analyses.
2.5. DAPI Uptake Assays
In vitro assays were performed on communication-incompetent (i.e., lacking ICGJ-
mediated communication) HeLa DH cells (Cat. No. 96112022, Merck KGaA) cultured in
DMEM (Cat. No. 41965039, Thermo Fisher Scientific) supplemented with 10% v/v heat-
inactivated FBS and penicillin/streptomycin solution (100 units/mL). Cells were plated at
60% confluence onto glass coverslips and transfected after 24 h with plasmids encoding
Cx43 or Cx26 fused to the yellow fluorescent protein Venus, using Lipofectamine 2000. Ex-
periments were performed the following day. In vivo assays were performed on GCaMP6s-
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or mCherry-expressing tumors grown in DSCs for four to five days and prepared as
described above.
For each sample, cells or tumors, multiple z-stacks (through-focus image sequences
obtained with a 2 µm step size) were acquired with the multiphoton microscope before
and after 30 min of incubation with DAPI (5 µM) and the HC opener/blocker under
examination, dissolved in proper extracellular medium (as specified in figure legends). To
test HC blockers, we used CFEM or CFEM supplemented with 5 mM of EGTA for in vitro
and in vivo assays, respectively; to test GSNO (1 mM), we used NEM. All drugs were
administered 20 min before starting the experiment. Multiphoton imaging was performed
with the 60× Nikon objective (Figures 2B–D and S2) or with a 25× water immersion
objective (XLPlanN25XWMP2, NA = 1.05, WD = 2 mm, Olympus Corporation, Tokyo,
Japan; Figure 5). For in vivo assays, we imaged cells within a depth of 20–60 µm from the
tumor surface. DAPI was excited at 780 nm and imaged through a blue emission filter
(460/50 nm, ET460/50m, Chroma Technology Corp, Bellow Falls, VT, USA).
2.6. Dual Focal Plane Multiphoton Imaging for Real-Time Detection of ATP Released by Tumor
Cells In Vivo
Whole-cell biosensors for ATP detection (ATP-WCBs) were obtained by transduction
of HEK-293T cells with a lentiviral vector (pHOT-P2Y2R, Addgene plasmid #159108) [24]
encoding the P2Y2 G-protein-coupled receptor (R) that mobilizes Ca2+ from intracellular
stores upon binding extracellular ATP with high affinity. ATP-WCBs were cultured in
DMEM/F-12 (Cat. No. 11320074, Thermo Fisher Scientific) supplemented with 10% v/v
heat-inactivated FBS and penicillin/streptomycin solution (100 units/mL). The day be-
fore the experiment, ATP-WCBs were plated at 50% confluence on 12-mm-round glass
coverslips coated with laminin (2.5 µg/cm2, Cat. No. 11243217001, Merck KGaA). On
the day of the experiment, ATP-WCBs were loaded for 30 min at 37 ◦C with fluorescent
cytosolic Ca2+ dye Fluo-8H AM (5 µM, Cat. No. 21091, AAT Bioquest) dissolved in
NEM supplemented with pluronic F-127 (0.1% w/v) and sulfinpyrazone (250 µM, Cat.
No. S9509, Merck KGaA) to prevent dye secretion. For the detection of fPDT-induced
ATP release by tumor cells in vivo, the coverslip plated with Fluo-8H-loaded ATP-WCBs
was carefully flipped upside-down and placed within the frame of the skinfold chamber
window, ~100–200 µm over the GCaMP6s-expressing tumor mass pre-loaded with AlPcCl,
as described above. The narrow gap between tumor and tumor-facing ATP-WCBs was
filled with CFEM to enhance HC opening, supplemented with ARL 67156 (100 µm, Cat. No.
A265, Merck KGaA, an ecto-ATPase inhibitor), to avoid rapid degradation of the released
ATP. To monitor fPDT-induced cytosolic Ca2+ wave in the tumor and concurrent ATP-WCB
responses, we oscillated the 60× objective lens of the multiphoton microscope between
the two focal planes using a piezo-electric actuator (PFM450E, Thorlabs, Inc., Newton, NJ,
USA). For each plane, images were acquired at a rate of 0.5 frame/s. For these experiments,
both Fluo-8H and GCaMP6s were excited at 920 nm and imaged through the 525/40 nm
band pass filter.
2.7. Imaging Intracellular Responses to Exogenously Applied ATP
B16-F10 cells expressing genetically encoded fluorescent Ca2+ indicators targeted to
the ER or mitochondria (G-CEPIA1er and CEPIA2mt, respectively) or the indicator for
Cas-3 activity were plated at 30% confluence onto laminin-coated round glass coverslips
24 to 48 h before experiments. On the day of the experiment, cells were washed in NEM and
placed on the stage of the two-photon microscope. For pressure application of exogenous
ATP, glass microcapillaries (Cat. No. G85150T-4, Harvard Apparatus, Holliston, MA, USA)
were pulled using a vertical puller (Cat. No. PP-830, Narishige Group, Tokyo, Japan) to
a fine tip (4–5 µm ∅) and filled with CFEM supplemented by 100 nM of ATP. The filled
pipette was connected with flexible tubing to a pneumatic Pico Pump (Cat. No. PV820,
World Precision Instrument, Sarasota, FL, USA) and placed at a distance of 25–30 µm from
the targeted cell with a micromanipulator (Cat. No. MX110, Siskiyou Corporation, Grants
Pass, OR, USA). Fluorescent indicator signals were recorded at a rate of 4 frames/s before,
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during and after 125 s of ATP ejection from the microcapillary in CFEM (same excitation
and emission wavelengths as in Section 2.4).
2.8. PDT Treatments and Longitudinal Studies by Time-Lapse Microscopy
For longitudinal studies, we performed PDT in two different configurations: spatially
confined PDT (scPDT, in which a subarea of tumor surface was irradiated; see below and
Figure 4A) and full PDT (in which the whole tumor surface was irradiated). To estimate
the minimum sample size for each experimental group, we set a probability α = 5% for
the type I error in the ANOVA test. Then, to fix β = 4α = 20% to obtain a test power of
1 − β = 80%, we computed the number of samples n using the formula:
n = 2[(zα/2 + zβ) × σ/∆]2, (1)
with zα/2 = 1.96 and zβ = 0.8416. We assumed σ = 0.35 (35%) as estimation for variability of
data (σ2 variance of data distribution) and ∆ = 0.75 as an expected effect size (minimum
normalized difference between averages that has biological significance). We treated in
parallel pairs of mice (DSC surgery, B16-F10 cell inoculation, onset of treatment) and
randomly assigned them to two different experimental groups. Experiments were repeated
until a minimum number of samples was collected for each experimental group (n = 3 for
scPDT, n = 4 for full PDT) and data were pooled. No mice were excluded from the study.
scPDT and full PDT treatments started two and four days after tumor cell seeding
in the DSC punch biopsy, respectively. B16-F10 wild type cells were used for calcein-AM
tumor viability assays, whereas B16-F10-mCherry were used for long-term longitudi-
nal studies of PDT effectiveness, both in scPDT and full PDT experiments. On the day
of the experiment, tumor-bearing mice were anesthetized with a cocktail of ketamine
(90 mg/kg; Lobotor, Acme S.r.l., Cavriago, Italy) and medetomidine (0.5 mg/kg; Domitor,
Orion Pharma, Espoo, Finland) via intraperitoneal injection. Next, tumors were sensi-
tized by multiple injections of NEM supplemented with PS (100 µM, total microinjected
volume = 10 µL) followed by incubation with PS-containing NEM for 1 h to ensure homo-
geneous PS absorption in the whole tumor mass. For calcein-AM viability assay, tumors
were also loaded with NEM supplemented with calcein-AM (10 µM, total microinjected
volume = 5 µL; Cat. No. C1430, Thermo Fisher Scientific). Thereafter, 10 µL of medium
supplemented with the HC opener/blocker under examination were microinjected in the
tumor. We used NEM (control); CFEM supplemented with EGTA (5 mM, for extracellular
Ca2+ chelation); CFEM supplemented with EGTA and FFA (100 µM, for HC inhibition in
EGTA conditions); NEM supplemented with GSNO (1 mM, for release of free NO, Cat. No.
N4148, Merck KGaA); NEM supplemented with GSNO and FFA (100 µM, for HC inhibi-
tion in GSNO conditions); and NEM supplemented with GSNO and TAT-Gap19 (150 µM)
or abEC1.1m (2 µM, for Cx43 or Cx26 HC inhibition in GSNO conditions, respectively).
Microinjections were performed using a controlled micropump (PHD Ultra Nanomite,
Cat. No. SKU 70-3601, Harvard Apparatus) that applied low and constant pressure to a
10-µL precision syringe (Cat. No. NANOFIL, World Precision Instrument) equipped with
a 36-gauge beveled needle (Cat. No. NF36BV-2, World Precision Instrument). The syringe
holder was mounted on a micromanipulator (Cat. No. MX110, Siskiyou Corporation) to
carefully insert the needle in the tumor mass without damaging it.
Tumor surface irradiation for PS activation was provided by the 671-nm laser properly
collimated in a 1.4-mm ∅ beam (scPDT) or a 5-mm ∅ beam (full PDT) by an adjustable
aspheric collimator (Cat. No. CFC-2X-B, Thorlabs, Inc.). For scPDT, the DSC was covered
with a round perforated matte mask (central hole diameter, 1.3 mm) to ensure confinement
of PS activation. Laser irradiation parameters were:
• 30 min of continuous irradiation, 5-mW average beam power across the mask hole,
378-mW/cm2 irradiance, 678-J/cm2 total delivered dose for scPDT;
• 1 h of continuous irradiation, 48-mW average beam power, 245-mW/cm2 irradiance,
880-J/cm2 total delivered dose for full PDT.
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Fluorescence images were acquired with a 2× super apochromatic microscope objec-
tive (TL2×-SAP, NA = 0.1, WD = 56.3 mm, Thorlabs, Inc.). Excitation light was provided by
a fluorescence lamp (pE-4000, CoolLED Ltd., Andover, NY, USA) equipped with excitation
filters suitable for calcein-AM (Cat. No. FF01-474/27-25, Semrock) and mCherry (Cat.
No. FF01-565/24-25, Semrock), respectively. Fluorescence emission was collected by a
1.4-megapixel monochrome scientific CCD camera (1500M-GE, Thorlabs, Inc.) through a
green (Cat. No. FF01-525/39-25, Semrock) or a red (Cat. No. FF01-615/45-25, Semrock)
band pass emission filter.
2.9. Micro-Computed Tomography (µCT) Analysis of Tumor Volumes
Four days after full PDT treatments, mCherry-expressing tumors were carefully
harvested under a fluorescence stereomicroscope (IC90 E, Leica, Wetzlar, Germany). Tumor
masses were then fixed in 4% paraformaldehyde (PFA) for 6 h and dehydrated with
consecutive washes in increasing concentration of ethanol up to 100% (50% overnight,
70% overnight, 96% 30 min, 100% overnight). The acquisition of tomographic datasets
was performed in 0.5-mL plastic micro-tubes, through a high-resolution 3D µCT Imaging
System (Skyscan 1172G, Bruker, Billerica, MA, USA), at 9.8 µm image pixel size. The
reconstruction was performed using a built-in NRecon Skyscan Software (Version 1.6.6.0,
Bruker). Manual image-by-image segmentations were performed to define specific volumes
of interest for automated volume measurements, using the Bruker Micro-CT Analyser
(Version 1.13) software.
2.10. Western Blot Analysis
Tumor masses were harvested five days after seeding either B16-F10 or B16-F10-
GCaMP6s cells in DSCs. Protein extracts from either tumors or cultured cells were prepared
in RIPA buffer (50 mM of Tris-HCl, pH 7.5, 150 mM of NaCl, 1 mM of EDTA, 1 mM of
EGTA, 1% NP-40, 1% sodium deoxycholate) supplemented with 1 mM PMSF and protease
inhibitor mix. Fifty micrograms of proteins were loaded on a 12% gel and western blot was
performed according to standard procedures. Anti-Cx43 (1:8000, #ab11370, Polyclonal, Ab-
cam, Cambridge, UK) and anti-Cx26 (1:250, #51-2800, Polyclonal, Thermo Fisher Scientific)
primary antibodies were used to detect Cxs. Optical density signal was normalized to that
of tubulin (1:2000, Cat. No. T6074, Monoclonal, Merck KGaA). Electrochemiluminescent
signal derived from luminol-horseradish peroxidase-conjugated secondary antibody reac-
tion was acquired and analyzed with an imaging system (Alliance, Uvitec Ltd., Cambridge,
UK). Heart and kidney were used as positive control tissues.
2.11. Histology and Immunofluorescence
Entire tumor-bearing DSC tissues were collected and fixed in 4% PFA overnight for
paraffin embedding. Microtome-sectioning was conducted to generate 8-µm sections that
were deparaffinized and rehydrated. For histological analysis, standard hematoxylin and
eosin staining was performed, and bright field images were acquired using an inverted
microscope equipped with a 20× objective (NA = 0.8) and a color camera (THUNDER
Imager DMi8, Leica). For immunostaining, antigen retrieval was performed in 1× citric
buffer at 95 ◦C for 10 min, followed by permeabilization with 0.5% Tryton X-100 in TBS-T
buffer for 10 min. After blocking for 1 h at room temperature in blocking buffer (10% FBS,
1% BSA in TBS-T), slides were incubated overnight in a humidified chamber at 4 ◦C
with primary antibody anti-Cx43 (1:100, #71-0700, Polyclonal, Thermo Fisher Scientific),
anti-Cx26 (1:200, #51-2800, Polyclonal, Thermo Fisher Scientific) or anti-P2Rs P2Y1R and
P2Y2R (1:100, #APR-009 and #APR-010, respectively, Polyclonal, knock out-validated,
Alomone Labs, Jerusalem, Israel). The next day, slides were washed and incubated with
cross-adsorbed Alexa Fluor 488 secondary antibody (1:500, #A-11008, Thermo Fisher
Scientific) for 1 h, then washed again and incubated with Alexa Fluor 594 conjugated
anti-MelanA primary antibody A103 (1:100, Cat. No. sc-20032 AF594, Monoclonal, Santa
Cruz Biotechnology, Inc., Dallas, TX, USA) for 2 h at room temperature. Afterwards,
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slides were washed and stained with DAPI (5 µM in TBS-T for 5 min). Washing was
performed in TBS-T between all steps. Fluorescence images were acquired at confocal TCS
SP5 microscope (Leica) equipped with a 63× oil immersion objective (HC PL Apo, UV
optimized, NA 1.4, Leica). Alexa Fluor 488 fluorescence signal was excited by a 488-nm
Argon laser and collected between 500 nm and 540 nm; Alexa Fluor 594 fluorescence signal
was excited by a 543-nm HeNe laser and collected between 625 nm and 700 nm; DAPI
fluorescence signal was excited by a 405-nm UV laser and collected between 415 nm and
480 nm. Using a sequential line-by-line protocol, images were acquired by averaging each
line 16 times (total pixel dwell time, 2.5 ms; pixel size, 96 nm).
2.12. Image Quantification
Image processing and data analysis were performed using Matlab (R2019a, The
MathWorks, Inc., Natick, MA, USA) and the open-source software ImageJ/Fiji (ImageJ-
win64). Extraction of fluorescence emission intensity F (fluorescent indicators, markers or
dyes) and traces representing time-dependent relative variation of F,
∆F/F0 = [F(t) − F0]/F0, (2)
where F0 denotes pre-stimulus value, were carried out as previously described [22].
Time integrals of ∆F/F0 traces were computed with the Matlab function trapz(). In
time-lapse microscopy experiments (Figures 4, 6 and S7), tumor remission was estimated as
decrease in fluorescent tumor surface area over time. The fluorescent area was defined as
the portion of the image where pixel signal was higher than a fixed threshold previously set
at image background level and measured with the ImageJ/Fiji plugin Measure. For DAPI
uptake quantification (Figures 2, 5 and S2), nuclear fluorescence of a cell was measured
within a round region of interest (ROI) as an average signal intensity of five consecutive z-
stack frames that intercepted the nucleus of that cell, using the ImageJ/Fiji plugin Measure.
2.13. Statistical Analysis
Mean fluorescence traces are shown in the graphs as point-by-point mean ± standard
error of the mean (s.e.m.) of ∆F/F0 or F/F0 signals. In histograms, mean values are
quoted ± s.e.m. Box plots were generated with the Matlab function boxplot(). Sample sizes
(n) for each experiment performed on the indicated number of tumors are declared in figure
legends. Parametric analysis of variance was performed by one-way ANOVA or the two-
tailed t-test (for multiple or pairwise comparisons, respectively); non-parametric statistical
analysis (when normality of data was rejected by the Shapiro-Wilk test) was performed
by the Kruskal-Wallis or the Mann-Whitney U test (for multiple or pairwise comparisons,
respectively), as indicated in figure legends. In the case of multiple comparison testing,
we used Bonferroni correction after the ANOVA test and Dunn-Sidak correction after the
Kruskal-Wallis test; detailed results are provided in Tables S1, S2, S4 and S6. In all statistical
analyses, a p-value (p) of < 0.05 indicates statistical significance: *, p < 0.05; **, p < 0.01;
***, p < 0.001; p > 0.05 is considered not significant (n.s.).
3. Results
3.1. Cx HCs Mediate the Propagation of Bystander Ca2+ Waves Elicited by Focal PS Activation In Vivo
For these experiments, we developed optically accessible B16-F10 murine melanomas
in the DSC preparation [25] (see Materials and Methods and Figure S1). To reveal time-
dependent variation of the [Ca2+]cyt, tumor cells were engineered to express the green
fluorescent Ca2+ indicator GCaMP6s [26] prior to cell seeding in the DSC. We allowed
tumors to develop in the DSC for 4 to 5 days, thereafter we focally stimulated a single cell in
the PS-loaded tumor mass with laser light (671 nm) focused in a 10-µm ∅ spot, a procedure
which we refer to as fPDT, and tracked the ensuing intercellular Ca2+ waves by intravital
multiphoton microscopy [27] (Figure 1; see Materials and Methods for details). For clarity,
melanoma cells within the field of view will be henceforth identified by a progressive
Cancers 2021, 13, 5062 9 of 26
“bystander cell order”, according to their distance from the irradiated cell (first neighbors of
the irradiated cell are designated as 1st order cells and so on; Figure 1A, bottom right). To
test HC involvement in Ca2+ wave propagation, we exploited the dependence of HC gating
on [Ca2+]ex [14,15] and compared experiments performed either in NEM (see Materials
and Methods, standard control conditions) containing 2 mM of Ca2+ or after incubation in
CFEM (see Ca2+-free conditions in the Materials and Methods) supplemented with 5 mM
of EGTA. On average, lowering the [Ca2+]ex in the DSC with EGTA increased ~four-fold
the variation of [Ca2+]cyt in bystander cells (Figure 1B,C). The simplest explanation for this
seemingly paradoxical effect is that the ER was the main source of the observed [Ca2+]cyt
increments, which is consistent with previous results using AlPcCl as PS [22].
Prior work showed the B16-F10 mouse melanoma cell line expresses low basal levels of
Cx26 and Cx43 [28,29]. To confirm the involvement of HCs in bystander signaling triggered
by fPDT, we tested the propagation of Ca2+ waves in CFEM supplemented with 5 mM
of EGTA, with or without the addition of non-specific Cx blockers CBX (100 µM) or FFA
(100 µM) [30]. We also tested TAT-Gap19 (150 µM) and abEC1.1m (1 µM), i.e., two selective
inhibitors of Cx HCs that do not affect IGJCs [23,31]. All four inhibitors decreased the
amplitudes of bystander Ca2+ responses compared to CFEM with EGTA alone (Figure 2A
and Table S1). To corroborate the opening of HCs in low [Ca2+]ex conditions, we used
the dye uptake technique [32], both in vitro (Figure S2) and in vivo (Figure 2B–D). In
addition, we assayed the expression of Cx43 and Cx26 by western blotting (Figure 2E)
and immunofluorescence analyses (Figure 2F, we also tested the presence of Cx30 and
Cx45, but they were not detected). Both Cx43 and Cx26 proteins were largely upregu-
lated in B16-F10 melanomas grown in DSCs compared to B16-F10 cells cultured in vitro
(Figure 2E). Consistent with these findings, CFEM supplemented with 5 mM of EGTA am-
plified fPDT-triggered intercellular Ca2+ waves substantially more in vivo (Figure 1) than
in vitro [22]. Together, the results summarized above suggested that HCs play a critical
role in bystander cell signaling associated with Ca2+ wave propagation in this syngeneic
melanoma mouse model.
3.2. Extracellular ATP Is Required for fPDT-Induced Ca2+ Wave Propagation
Extracellular ATP may mediate intercellular Ca2+ waves by activating P2 purinocep-
tors on cell plasma membranes, with or without involvement of inositol 1,4,5-trisphosphate
(IP3) diffusion through IGJCs [33]. Because HCs seem to be important for the intercellular
Ca2+ waves described above, and given that open HCs are permeable to ATP, our next goal
was to determine whether ATP was released during fPDT-triggered Ca2+ wave propaga-
tion in vivo. To test this hypothesis, we used ATP-WCBs developed in the lab, with ATP
sensitivity in the nM range [24]. Cells were plated over the inner surface of the coverslip
that sealed the DSC and loaded with a chemical fluorescent indicator selective for cytosolic
Ca2+ (Fluo-8H, Figure 3A). The medium intercalated between tumor and ATP-WCBs in
the sealed DSC was CFEM (to favor HC opening), supplemented with ARL 67156, an
ecto-ATPase inhibitor [34], used to prevent rapid ATP degradation (EGTA was omitted
because it interfered with ATP-WCBs activity).
Dual focal plane, intravital multiphoton confocal Ca2+ imaging showed that fPDT-
evoked Ca2+ waves in GCaMP6s-expressing tumors were paralleled by time-delayed Ca2+
signals in overlying ATP-WCBs. Supplementing the extracellular medium with apyrase
(APY, 250 U/mL), an enzyme that catalyzes ATP hydrolysis [35], reversibly inhibited
Ca2+ wave propagation in both tumor and ATP-WCBs (Figure 3B,C). In the absence of a
PS-loaded tumor, exposure of ATP-WCBs to the laser beam used for fPDT did not elicit
any Ca2+ response (Figure S3). We obtained similar results from fPDT trials performed
in the same conditions as those presented in Figures 1 and 2A (incubation of DSC tumor
with CFEM supplemented with 5 mM of EGTA, Figure 3D). Together, these in vivo fPDT
results indicate that (i) ATP-WCBs responded to the ATP released by tumor cells after
PS activation; and (ii) ATP release was required for Ca2+ wave propagation in bystander
tumor cells.
Cancers 2021, 13, 5062 10 of 26
Figure 1. Intercellular calcium (Ca2+) waves triggered by focal photodynamic therapy in vivo. (A) Shown are GCaMP6s
fluorescence emission (F) variations (∆F = F − F0, where F0 = pre-stimulus value) at different time points after the onset
of laser irradiation in standard conditions (normal extracellular medium containing 2 mM of Ca2+, NEM) or after 20 min
incubation in Ca2+-free extracellular medium supplemented with ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-
tetraacetic acid (EGTA, 5 mM). The contour of the irradiated cell is highlighted in the images captured at 5 s. Bystander cells
were identified by ordinal numbers according to the distance from the irradiated cell (see, for an example, the contoured
cells in the image at 70 s in EGTA conditions); scale bar: 20 µm; (B) Single-cell ∆F/F0 traces [mean (solid lines) ± standard
error of the mean (s.e.m., dashed lines)] generated as pixel signal average within regions of interest contouring the cell
focal plane section for each bystander cell order (from 1st to 6th); pooled data from n ≥ 6 experiments in 3 tumors for both
conditions: green traces, EGTA; blue traces, NEM; vertical dashed lines mark the onset of irradiation at t = 10 s; (C) Area
under ∆F/F0 curves (A, inset) computed between t = 10 s and t = 80 s (mean ± s.e.m.) vs. bystander cell order (abscissa):
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Figure 2. Connexin (Cx) hemichannels (HCs) expressed in melanoma cells mediate the propagation of calcium (Ca2+)
waves induced by focal photodynamic therapy (fPDT) in vivo. (A) Pooled results of fPDT trials in GCaMP6s-expressing
dorsal skinfold chamber (DSC) tumors in the following conditions: Ca2+-free extracellular medium (CFEM) supple-
mented with ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA, 5 mM); normal extracellular
medium containing 2 mM of Ca2+ (NEM, control); CFEM supplemented with EGTA (5 mM) plus carbenoxolone
(CBX, 100 µM) or flufenamic acid (FFA, 100 µM) or TAT-Gap19 (150 µM) or abEC1.1m (1 µM). The histogram shows
the area under GCaMP6s ∆F/F0 traces (A, inset) computed between the onset of fPDT (t = 10 s) and the end of
the observation time window (t = 80 s) for each bystander cell order (abscissa); pooled data [mean ± standard er-
ror of the mean (s.e.m.)] for n ≥ 6 experiments in at least 2 different tumors for each condition. a.u., arbitrary
units; *, p < 0.05; ***, p < 0.001, the Kruskal-Wallis test (for post hoc pairwise comparisons, see Table S1). Data for
EGTA and NEM conditions are also shown in Figure 1C; (B–D) In vivo 4′,6-Diamidine-2′-phenylindole dihydrochlo-
ride (DAPI) uptake experiments: GCaMP6s-expressing DSC melanomas were incubated with DAPI (5 µM) dissolved
in: CFEM supplemented with 5 mM of EGTA; NEM; CFEM supplemented with 5 mM of EGTA plus FFA (100 µM)
or TAT-Gap19 (150 µM) or abEC1.1m (1 µM). Fluorescence images were acquired at 5 min intervals up to 30 min;
(B) Representative images acquired before (t = 0 min) and after 30 min of DAPI incubation in EGTA conditions; scale
bar: 20 µm; (C) Relative variation of nuclear DAPI fluorescence intensity [F(t)/F0] in tumor cells vs. time during dye
uptake in EGTA conditions (mean ± s.e.m., n = 20 cells, 2 tumors). The red dashed line was computed by data fitting
with the shown function f (t) (parameter values: a = −0.1754, b = 0.0647 min−1); (D) Box plots showing the distributions
of ∆F = F(30 min) − F0 for DAPI measured in n ≥ 12 nuclei for each condition. Red horizontal bars indicate the median.
***, p < 0.001, the Kruskal-Wallis test (for post hoc pairwise comparisons, see Table S2); (E) Representative western blots for
Cx43 (top) and Cx26 (bottom) expression in tumors (T) derived from B16-F10 or B16-F10-GCaMP6s cells and grown in DSCs
(denoted as B16-F10 T and B16-F10-GCaMP6s T, respectively) compared with B16-F10 or B16-F10-GCaMP6s cells grown
in culture dishes; graphs on the right show the corresponding relative optical density (mean ± s.e.m., n = 4 independent
experiments; **, p < 0.05, ANOVA on Ranks; ***, p < 0.001, ANOVA); Detailed information about the western blotting can
be found at Figure S9. (F) Confocal fluorescence images obtained by immunostaining with antibodies selective for Cx43
(top left, green), Cx26 (bottom left, green) and MelanA (right, red) in representative sections of melanomas grown in DSCs;
nuclei were stained with DAPI; scale bar: 10 µm.
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Figure 3. Whole-cell biosensors for adenosine triphosphate (ATP) detection (ATP-WCBs) are activated by extracellular ATP
released during the propagation of calcium (Ca2+) waves induced by focal photodynamic therapy (fPDT) in the dorsal
skinfold chamber (DSC). (A) Schematic representation of the multiphoton microscope objective lens oscillating between
two focal planes for real-time detection of ATP release during fPDT stimulation (left, GCaMP6s-expressing tumor; right,
Fluo-8H-loaded ATP-WCBs); (B) Representative back-projections of ∆F = F − F0 (with F0 pre-stimulus value) frames
acquired from tumor (top) and ATP-WCBs (bottom) during fPDT stimulation in the absence of apyrase (−APY, left) or
in its presence (+APY, 250 U/mL, right) in Ca2+-free extracellular medium (CFEM). Red circles mark the location of the
photoactivation laser beam; scale bar: 20 µm; (C) Average Ca2+ responses of bystander melanoma cells (top) and ATP-WCBs
(bottom) to fPDT before (left) and after (right) addition of APY to the extracellular medium; ∆F/F0 signals [mean (solid lines)
± standard error of the mean (s.e.m., dashed lines)] are shown for each bystander cell order. Results are representatives of
n ≥ 3 experiments performed in 2 tumors. Vertical dashed lines mark the onset of laser irradiation (t = 5 s); (D) Effect of
APY on the amplitudes of fPDT-induced Ca2+ waves in CFEM supplemented with 5 mM of EGTA; the histogram shows the
area under GCaMP6s ∆F/F0 signals (A, see inset) computed for each bystander cell order in the absence of APY (−APY,
green bars, also shown in Figures 1C and 2A) or in its presence (+APY, black bars); data (mean ± s.e.m.) were pooled from
n ≥ 6 experiments in at least 2 different melanomas for each condition; a.u., arbitrary units; **, p < 0.01; ***, p < 0.001; the
Mann-Whitney U test.
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When extracellular Ca2+ is chelated with EGTA, the P2 purinoreceptors that can
still generate Ca2+ signals in response to extracellular ATP, by mobilizing Ca2+ from the
ER through IP3Rs, are the G-protein-coupled P2YRs [36]. To confirm their expression in
our tumor samples, we performed immunofluorescence experiments with specific and
knock-out-validated antibodies against P2Y1R and P2Y2R and determined that both were
detectable (Figure S4).
3.3. Intratumor Injection of EGTA Prior to PS Activation Boosts Bystander Cell Killing In Vivo
Based on the findings reported above, we hypothesized that potentiating HC activity
by lowering the [Ca2+]ex in the tumor microenvironment with EGTA might broaden the
extent of cytotoxic bystander effects in this melanoma mouse model. To test this hypothesis,
we seeded B16-F10 melanoma cells on the dermis exposed by performing a 4-mm ∅
punch biopsy within the DSC. Two days after seeding, we loaded the melanoma with
both PS and a live cell marker (calcein-AM) that becomes fluorescent in (and therefore
labels only) cells with active intracellular esterases [37]. Twenty minutes prior to PS
activation, CFEM supplemented with 5 mM of EGTA or NEM (control conditions) was
administered via intratumor microinjection. Next, we covered the DSC with a perforated
matte mask and limited laser irradiation to within 10% of the melanoma area (Figure 4A),
a procedure we refer to as scPDT (see Materials and Methods). Thereafter, we removed
the mask and performed time-lapse intravital fluorescence microscopy with a 2× objective
to estimate post-irradiation bystander cell viability in a field of view encompassing the
whole tumor surface. Finally, at the end of a three-hour observation period, we reloaded
the melanoma with calcein-AM in the DSC to counteract the unavoidable slow leakage of
dye through the intact cell membrane of live cells [38]. In control conditions, ~50% of the
melanoma surface remained fluorescent after calcein-AM reloading (Figure 4B,C, top). In
contrast, in samples treated with CFEM supplemented with 5 mM of EGTA, we observed
a near-complete loss of post-irradiation fluorescence, which persisted after calcein-AM
reloading (Figure 4B,C, bottom). Neither laser irradiation in the absence of the PS nor EGTA
microinjection without laser irradiation significantly affected calcein-AM fluorescence
emission (Figure S5), indicating that its post-irradiation waning was genuinely caused by
PS activation. A possible explanation for the persistent loss of calcein-AM fluorescence after
dye reloading is that PS activation induced a massive HC opening, which would doom
cells exposed to prolonged membrane permeabilization via HCs [14]. Consistent with this
interpretation, chelation of extracellular Ca2+ with EGTA, a condition that promoted HC
opening in our melanoma model (Figure 2B–D), enhanced bystander cell killing following
PS excitation.
Since mobilization of internal Ca2+ stores seemed to be a key process in melanoma
response to PS activation in vivo, and given that ER-mitochondria Ca2+ transfer is a key
regulatory mechanism in Ca2+-dependent apoptosis and anti-cancer therapies [39–42],
we investigated inter-organellar Ca2+ signaling in B16-F10 tumors grown in DSCs and
expressing Ca2+-selective genetically encoded indicators targeted to subcellular compart-
ments (Figure 4D) [43]. Following focal PS activation in NEM, these indicators revealed
a rapid release of Ca2+ from the ER (Figure 4E,F, top) paralleled by Ca2+ uptake into
mitochondria (Figure 4E,F, bottom) in both irradiated and bystander cells. Additional
experiments on B16-F10 melanomas expressing a fluorescent indicator for Cas-3 activity
(Figure 4G,H) [44] revealed Cas-3 cleavage in bystander cells within tens of seconds of laser
irradiation (Figures 4I,J and S6). Together with prior work [20–22], these results indicate
that PS activation efficiently triggered Ca2+-dependent apoptotic pathways [39–42] in both
irradiated and bystander melanoma cells.
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Figure 4. In vivo intratumor injection of ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) prior to
spatially confined photodynamic therapy (scPDT) boosts bystander cell killing via calcium (Ca2+)-dependent apoptotic
pathways. (A–C) B16-F10 melanomas grown in the dorsal skinfold chamber (DSC) were loaded with the photosensitizer
(PS) and partially irradiated (scPDT, 30 min duration, irradiance ~378 mW/cm2) after microinjection of normal extracellular
medium (NEM, control conditions) or Ca2+-free extracellular medium supplemented with 5 mM of EGTA (EGTA conditions).
Tumor cell demise was assayed by time-lapse microscopy using calcein-AM (co-loaded with PS); (A) DSC titanium
frame (left) with applied opaque mask (right) used to restrict melanoma irradiation in scPDT experiments (central hole
diameter = 1.3 mm); scale bar: 1 cm; (B) Post-irradiation variation of melanoma surface area with persistent calcein-AM
fluorescence in control (NEM; n = 4, blue) and EGTA (n = 3, green) conditions. Interpolating curves (dashed lines)
were computed by data fitting with the function f(t) = 1 − a + ae−b(t+c) (for parameter values, see Table S3). *, p < 0.05;
**, p < 0.01, two-tailed t-test; (C) Representative results of time-lapse fluorescence imaging with calcein-AM. Images were
acquired before and after scPDT (within white circles) at shown time points; the black down arrow marks the time point of
calcein-AM reloading in the tumors (3 h 30 min); scale bars: 1 mm; (D–J) Experiments were performed in B16-F10 syngeneic
melanomas exposed to NEM, expressing one of the following genetically encoded fluorescent indicators: R-CEPIA1er, a
Ca2+ indicator targeted to the endoplasmic reticulum (ER, D–F, top); CEPIA2mt, a Ca2+ indicator targeted to mitochondria
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(D–F, bottom); an indicator for caspase-3 (Cas-3) activation (G–J); (D,H) Representative fluorescence images of melanoma
cells expressing the aforementioned Ca2+ (D) or Cas-3 indicators (H); scale bars: 20 µm; (E,I) Representative color-coded
∆F/F0 signals in the irradiated cell and surrounding bystander cells; black traces are representative results obtained in the
absence of PS (−PS, negative control). The vertical dashed lines mark the onset of laser irradiation (t = 10 s); (F) Rates of
Ca2+ signals computed up to the 4th bystander cell order as the absolute value of the average slope of the post-irradiation
linear descending (ER, top) or ascending (mitochondria, bottom) trace segment. Data were pooled from n ≥ 10 experiments
in at least 2 tumors for each condition and quoted as mean values ± standard error of the mean (s.e.m.); (G) Schematic
representation of the mechanism of action for the fluorescent Cas-3 indicator; (J) Cas-3 activation rate computed up to the
3rd bystander cell order as the absolute value of the average slope of the linear descending post-irradiation trace segment.
Data (mean ± s.e.m.) were pooled from n = 4 experiments in 2 tumors.
To examine the consequences of these phenomena, we performed a longitudinal
study based on time-lapse microscopy up to three days after scPDT in B16-F10 melanomas
tagged with mCherry, a cytosolic fluorescent marker (Figure S7). mCherry fluorescence
persisted in more than 75 % of the tumor surface at 24 h post-irradiation, slowly decreasing
to ~65 % within 3 days in samples microinjected with NEM (control conditions) prior to
laser irradiation. In contrast, mCherry fluorescence become undetectable within the first
24 h post-irradiation in samples microinjected with CFEM supplemented with 5 mM of
EGTA, indicating that melanoma cells were almost completely eradicated from the tumor
surface (consistent with the results of Figure 4B,C). The addition of FFA (100 µM) to the
microinjected CFEM supplemented with 5 mM of EGTA reduced bystander cell killing to
the level of controls performed in NEM (Figure S7 and Table S4).
3.4. GSNO Activates HCs and Improves PDT Outcome in Murine Melanoma In Vivo
Together, the results summarized above indicate that intratumor injection of EGTA
increased HC-mediated bystander tumor cell death induced by scPDT. However, the bene-
ficial impact of chelation therapy has been questioned [45,46]. An alternative procedure to
bias HCs towards the open state is the use of GSNO, an endogenous NO donor [47] that
acts in a metabolic state-dependent manner [48–50].
To determine whether the antitumor response induced by PDT could be enhanced
by GSNO, we used mCherry-expressing melanomas grown for 4 days in the 4-mm ∅
punch biopsy. We first microinjected tumors with GSNO (1 mM) dissolved in NEM 20 min
before performing in vivo DAPI uptake assays. Multiple through-focus image sequences
(z-stacks) were acquired before and after 30 min of incubation with DAPI (5 µM). GSNO
significantly enhanced DAPI uptake in vivo compared to controls (microinjection of NEM)
and the effect of GSNO was inhibited by FFA (Figure 5), suggesting that GSNO promoted
the opening of HCs in our syngeneic melanoma model. On this ground, we irradiated the
whole surface area of other PS-loaded melanomas with a 5-mm ∅ laser beam for 1 h, a
procedure hereafter referred to as full PDT (see Materials and Methods) in the absence or
in the presence of microinjected GSNO (1 mM). Thereafter, we monitored post-irradiation
mCherry fluorescence signal loss by time-lapse microscopy (Figure 6A,B). Four days after
treatments, animals were humanely euthanized, tumors were harvested, and their volumes
were measured with high precision by µCT analysis (see Materials and Methods) [51]
(Figure 6C,D). A parallel set of samples was used for histology (Figure 6E). On average,
full PDT reduced tumor volumes in samples microinjected with GSNO to 14% of the value
achieved without GSNO (p = 0.044). Importantly, addition to the microinjected GSNO
of specific HC blockers, either TAT-Gap19 (150 µM) or abEC1.1m (2 µM), abolished the
observed reduction of tumor volumes, which were comparable to those obtained in control
conditions (p = 0.80 for TAT-Gap19, p = 0.99 for abEC1.1m). In contrast, the volumes of
GSNO-treated vs. NEM-treated melanomas that had not been laser irradiated after PS
loading were not significantly different (p = 1). Consistent with these results, in B16-F10
cells stimulated in vitro with exogenously applied ATP (100 nM in CFEM), we detected
Ca2+ release from the ER (via G-protein-coupled P2YRs, Figure S4) and Ca2+ uptake into
mitochondria, but we also detected Cas-3 activation only in cell cultures that had been
pre-incubated with 100 µM of GSNO (Figure S8).
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Figure 5. In vivo 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI) uptake assays. (A) Representative fluorescence
intensity (F) images of mCherry-expressing melanomas acquired approximately 50 µm below tumor surface after 30 min of
incubation with DAPI (5 µM) dissolved in: normal extracellular medium (NEM, control conditions: −GSNO); NEM contain-
ing 1 mM of S-Nitrosoglutathione (+GSNO); NEM containing 1 mM of GSNO plus 100 µM of flufenamic acid (+GSNO +FFA);
scale bar: 20 µm; a.u., arbitrary units; (B) Box plots showing the distributions of ∆F = F(30 min) − F0 (F0 = F before DAPI
incubation) for DAPI fluorescence intensity measured in n ≥ 74 nuclei in −GSNO (3 tumors), +GSNO (3 tumors) or +GSNO
+FFA (2 tumors) conditions; red horizontal bars represent the median; bottom and top edges of the blue boxes indicate
the 25th and 75th percentiles, respectively; black tails of the boxes mark the most extreme data points in the distribution.
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Figure 6. Microinjected S-Nitrosoglutathione (GSNO) enhances the efficacy of full photodynamic therapy (PDT) in murine
melanoma by activating connexin hemichannels. (A) Photosensitizer (PS)-loaded melanomas grown in the dorsal skinfold
chamber (DSC) and expressing mCherry were irradiated (full PDT, 60 min, irradiance ~245 mW/cm2) 20 min after
microinjection of: normal extracellular medium (NEM, control conditions: −GSNO); GSNO (1 mM) dissolved in NEM
(+GSNO); GSNO (1 mM) plus TAT-Gap19 (150 µM, +TAT-Gap19) dissolved in NEM or abEC1.1m (2 µM, +abEC1.1m)
dissolved in NEM; tumor cell demise was assayed by time-lapse microscopy of red fluorescent mCherry. Shown are
representative images acquired before and after full PDT in −GSNO and +GSNO conditions at shown time points; scale
bar: 1 mm; (B) Melanoma surface area with persistent mCherry post-irradiation fluorescence in −GSNO (blue, n = 4),
+GSNO (gray, n = 4), +TAT-Gap19 (magenta, n = 4) and +abEC1.1m (red, n = 4) conditions. Interpolating curves (dashed
lines) are data fitting with the function f(t) = 1 − a + ae−b(t+c) (for parameter values see Table S5). *, p < 0.05; **, p < 0.01,
the Mann-Whitney U test; (C–E) Melanomas were harvested 4 days after treatment. Controls were loaded with PS and
microinjected but were not irradiated (No irradiation); (C) Tumor masses excised after treatment in each of the six conditions,
scale unit: cm; (D) Tumor volumes measured by micro-computed tomography analysis; black horizontal bars mark the
median. n.s., not significant; *, p < 0.05, the Kruskal-Wallis test (for post hoc pairwise comparisons see Table S6); (E)
Hematoxylin and eosin staining of tumor-bearing DSC tissues exposed to full PDT in −GSNO or +GSNO conditions. Black
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Together, these experiments highlight a central role for HC activation in PDT for
cancer and suggest that GSNO is a candidate adjuvant for PDT in clinical settings.
4. Discussion
We conducted this study in a syngeneic mouse melanoma model, working with
B16-F10 cells grown in the DSC preparation [25] that allowed us to gain optical access
to the processes triggered by PDT. By using a combination of intravital multiphoton
microscopy [27], ATP-WCBs [24], and genetically encoded fluorescent indicators [26,43,44]
expressed in B16-F10 tumors, we determined that (i) photoactivation of a PS suitable for
melanoma treatment efficiently triggered Ca2+-dependent cell death pathways in both
irradiated and bystander melanoma cells; (ii) HC activity and ATP release were key factors
for the induction of bystander cell death; and (iii) bystander cell killing and antitumor
response elicited by PDT were greatly enhanced by combination treatment with GSNO,
which promoted HC opening in these experimental conditions.
The scheme that emerges from our present work and published results is one in
which both NO and Ca2+ signaling, mediated chiefly by the ATP/P2YR/PLC/IP3 signal
transduction cascade, are essential constituents of propagation and regeneration of ROS and
NO production in the bystander cells, and are ultimately responsible for bystander effects.
4.1. HC-Mediated Ca2+ Signaling and ATP Release as Critical Components of Bystander Tumor
Cell Killing
Bystander effects triggered by PS activation were mediated by intercellular Ca2+ waves
that required release of ATP from cell cytosol to extracellular milieu through HCs. Both
Cx43 and Cx26 were largely upregulated in B16-F10 cells grown in vivo (this work) com-
pared to cells cultured in vitro [28,29]. Consistent with these findings, lowering the [Ca2+]ex
with EGTA, which removes HC blockade due to extracellular Ca2+ [14,15], amplified in-
tercellular Ca2+ waves triggered by focal PS activation substantially more in vivo (this
work) than in vitro [22], supporting a role for HCs in melanoma sensitization to bystander
cell death.
In the extracellular milieu, the ATP released through HCs may couple with Ca2+-
mobilizing purinoceptors on the plasma membrane of neighboring cells and develop
intercellular Ca2+ waves [24,33,38,52]. Since the open probability of HCs is modulated by
the [Ca2+]cyt [16–18], a positive-feedback loop involving the control by [Ca2+]cyt of HCs
may lead to an overall augmented ATP-induced ATP release [52] that would increase both
the volume invaded by Ca2+ waves and the [Ca2+]cyt increments in individual bystander
cells, as reported here (Figure 1).
To inhibit Ca2+ wave propagation in vivo, we used CBX, FFA, TAT-Gap19, and
abEC1.1m. The first two drugs are widely used non-specific inhibitors of connexin-made
channels with well-known side effects [53–55]. In contrast, TAT-Gap19 and abEC1.1m are
among the most selective HC inhibitors currently available [23,31]. We showed here that
FFA, as well as TAT-Gap19 and abEC1.1m, not only hampered Ca2+ wave propagation but
also the uptake of DAPI into melanoma cells (Figure 2A–D). Dye uptake (with DAPI and
other fluorescent permeant molecules) is a standard method for studying HC permeability
and dynamics in a quantitative, sensitive, and versatile manner [32]. Both chelation of
extracellular Ca2+ with EGTA and intratumor injection of GSNO, which opens HCs even
when [Ca2+]ex is at mM levels [48–50], increased DAPI uptake in vivo. When used in com-
bination with PS activation, both EGTA and GSNO increased bystander cell killing, and
GSNO dramatically reduced the residual melanoma mass after PDT (Figures S7 and 6 ).
Although GSNO can affect several targets, the fact that its effects were drastically inhibited
by FFA, TAT-Gap19, and abEC1.1 support our hypothesis that HCs are critical components
of bystander signaling in anti-melanoma PDT. Considering the ability of PDT to promote
immunogenic cell death (ICD) mediated by the release of damage-associated molecular
patterns (DAMPs), and given that ATP is a prime DAMPs [56], it is tempting to speculate
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that ICD contributed to the remarkable reduction of post-PDT tumor mass in the presence
of GSNO. Further studies are required to address this crucial issue.
The rise in [Ca2+]cyt triggered by PS activation was dominated by Ca2+ release from the
ER. IP3R channels serve as the principal mechanism to mobilize Ca2+ from ER stores [57].
Our prior work with B16-F10 melanoma cells in vitro [22] suggested that part of the
[Ca2+]cyt increase was mediated by the superoxide anion produced by PS activation and
its breakdown product hydrogen peroxide (H2O2), which can directly activate IP3Rs by
oxidation of thiol groups of critical cysteine residues [58]. In addition, increased levels
of H2O2 have been shown to promote HC opening independently of [Ca2+]ex in cultured
cells in vitro [59]. We also previously highlighted the importance of ER-mitochondria Ca2+
transfer in the induction of a second generation of mitochondrial ROS both in irradiated
and bystander cells following PS activation in vitro [22]. Here, in vivo experiments with
ATP-WCBs and genetically encoded fluorescent indicators confirmed ATP-dependent Ca2+
efflux from the ER, paired with mitochondrial Ca2+ uptake followed by rapid activation
of Cas-3 both in irradiated and bystander cells (Figure 4). In B16-F10 cultured cells,
activation of P2YR by extracellular ATP was not sufficient, per se, for Cas-3 activation, but
required the presence of the NO donor GSNO (Figure S8). On this ground, a schematic
model for HC-related signaling downstream of PS photoactivation is presented in Figure 7
based on current understanding of mitochondria-associated ER membrane structure and
function [60]. The model summarizes graphically the most likely processes that underlie the
catastrophic combination of ER-mitochondrial Ca2+ signaling events, which are crucial to
regulate tumor cell fate by promoting bystander cell death. Remarkably, (i) these molecular
processes occurred in non-irradiated/bystander tumor cells within tens of seconds, with a
time delay dependent on the distance from the irradiated cell; and (ii) bystander killing
was augmented under conditions that favored HC opening.
4.2. Translational Significance of These Studies
Wu and colleagues showed that Cx-made channels increase Photofrin-mediated PDT
phototoxicity in tumors derived from Cx-transfected HeLa cells and suggested, as a bene-
ficial therapeutic strategy, a transitory elevation in Cxs expression [71,72]. However, Cxs
play complex roles in tumor progression [73,74], therefore controlling their intratumor
expression can be challenging; even more so given that Cxs have been found up-regulated
in, and correlated to, increased metastasis [28,29]. In contrast, intratumor administration
of a transiently active HC opener, such as GSNO [48–50], as carried out in this study,
appears more feasible and far less risky, also considering that GSNO is an endogenous NO
donor [47] and that NO is a byproduct of AlPcCl photoactivation [20].
In published work, NO improved lopinavir anti-cancer activity in syngeneic B16
models [75] and was required to efficiently induce H2O2-mediated cytotoxicity in B16
cultured cells [76]. Rapozzi and colleagues proposed a synergistic effect of NO donors
and PS to amplify PDT-mediated cytotoxicity [77,78]. However, accumulating evidence
reveals that, in sub-optimal PDT treatments, low-level photodynamic stress can induce
NO-mediated tumor resistance and pro-survival effects in different cancer types [79,80].
Since the overall amount of produced NO depends on the PS used, irradiation settings,
GSNO concentration, and targeted tissue, the parameters for combined treatment must be
carefully determined in clinical settings. Development of novel selective HC-activating
antibodies to be used as PDT adjuvants, instead of aspecific compounds, would be an
important step towards future clinical applications. Further improvements in PDT are
likely to accrue also from PS with large ROS/RNS generation capacity and absorption
bands in the near infrared region [81,82], where tissue absorption is minimal [83].
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Figure 7. Schematic model for connexin (Cx) hemichannels (HC)-related signaling downstream of photosensitizer (PS)
activation. (1) Reactive oxygen species (ROS), generated directly or indirectly after PS photoactivation [22], activate inositol
1,4,5-trisphosphate (IP3) receptors (Rs), promoting calcium (Ca2+) release from the endoplasmic reticulum (ER). (2) The
rise in cytosolic Ca2+ concentration gates HCs from the inside, (3) permitting the release of adenosine triphosphate (ATP)
from cytosol to extracellular milieu. (4) The released ATP activates metabotropic P2YRs and consequent IP3 production
via G-protein-coupled activation of phospholipase C (PLC). (5) IP3 binding to IP3R in the ER potentiates ROS-mediated
Ca2+ release. (6) This enhances Ca2+ uptake into the mitochondrial matrix via voltage-dependent anion-selective channel 1
(VDAC1) in the outer mitochondrial membrane (OMM) and mitochondrial Ca2+ uniporter (MCU) in the inner mitochondrial
membrane (IMM). The tight spacing between ER and mitochondria, which is key for efficient ER-mitochondria Ca2+ transfer,
is regulated by mitofusin (Mfn) proteins and fetal and adult testis-expressed 1 (FATE1). (7) Within the matrix, Ca2+ regulates
the tricarboxylic acid (TCA) cycle by controlling the activity of three dehydrogenases, promoting increased synthesis of
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2) and consequent augmented ATP
production by complex V (ATP synthase) of the electron transport chain (ETC). (8) Ca2+ entry also drives potassium
(K+) and water (H2O) influx into the matrix. (9) The increased internal pressure squeezes hydrogen peroxide (H2O2)
out of mitochondrial cristae (C), reinforcing ROS-mediated opening of the IP3R and blockade of the Sarco-Endoplasmic
Reticulum Ca2+ ATPase (SERCA) pump, which leads to irreversible ER emptying. (10) Ca2+ overload of the mitochondrial
matrix enhances ROS levels and H2O2 mainly via complex I and III in the ETC, promoting mitochondrial permeability
transition pore (mPTP) opening. (11) Prolonged opening of the mPTP causes depolarization of the IMM and swelling of
the mitochondrial matrix, which ensues in the rupture of the OMM. (12) Consequently, cytochrome c (Cyt c) is released,
thus promoting apoptotic cell death (13). ICS, intracristal space (see [57,58,60–68]). These events are exacerbated by nitric
oxide (NO), a key diffusible byproduct of aluminum phthalocyanine chloride photoactivation in irradiated cells [20]. In
bystander cells, NO concentration is increased above diffusion levels by Ca2+-dependent enzymatic production [20–22]
and can be further increased by administration of a NO donor (S-Nitrosoglutathione), as accomplished in this article. NO
favors the opening of HCs in different cell types and Cx species [48,49,69]. In this context, it potentiates the ATP release
that subtends Ca2+ wave propagation. In addition, NO can inhibit the ETC, particularly complex IV, but also complex I, III,
and II, by imparting modifications, such as S-nitrosation and nitration to selected residues [70]. Inhibition of complex IV
by NO enhances the production of mitochondrial ROS [68]. The combination of NO with superoxide anion can generate
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5. Conclusions
Our study in a clinically relevant tumor model demonstrates that bystander effects in
PDT proceed by conveying death signals from irradiated to bystander tumor cells via ATP-
dependent ATP release through HCs, and these signaling mechanisms can by amplified
by HC openers. These findings have a clear translational significance and suggest that
modulators of HC activity can work synergistically with PDT to improve tumor eradication.
Recently, Ramadan and colleagues described a role for HCs in radiation-induced dam-
age in endothelial cells [84], and ATP release through HCs following γ-radiation has been
reported in cultured B16 melanoma cells [85], suggesting that the strengthening of ATP-
dependent paracrine signaling demonstrated in this study could also be beneficial in other
therapeutical modalities, such as radiotherapy, which is known to evoke bystander effects.
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